期刊文献+

鲍氏不动杆菌blaOXA-23基因定位及其临床意义 被引量:3

Genetic Supports of blaOXA-23 in Acinetobacter baumannii and Their Clinical Significance
下载PDF
导出
摘要 目的研究鲍氏不动杆菌blaOXA-23的基因背景,探讨不动杆菌属耐药性产生与抗菌药物使用的关系。方法连续筛选法获得耐亚胺培南鲍氏不动杆菌;PCR检测碳青酶烯酶基因;ERIC-PCR研究菌株遗传相关性;质粒接合实验及blaOXA-23杂交等研究OXA-23基因定位。结果24株中筛选出10株耐药菌,其中有6株检测到blaOXA-23基因;且菌株呈多克隆特点;DNA杂交发现blaOXA-23与整合子无关。结论blaOXA-23可存在于对亚胺培南敏感的不动杆菌属中;抗菌药物选择压力强化了blaOXA-23阳性菌的种群优势,导致耐药性产生;提示应合理应用此类抗菌药物。 OBJECTIVE To study the genetic supports of OXA-23 in Acinetobacter baumannii isolates and investigate the relationship between imipenem resistance acquiring and use of antibiotics.METHODS Consecutive selection of the 24 highly susceptive A.baumannii clinical isolates by imipenem was carried out.Genes of carbapenemases were detected by PCR and the colonial relationship of these isolates was evaluated by ERIC-PCR.Plasmids conjugation experiments and blaOXA-23 hybridization were performed to explore the gene location of blaOXA-23.RESULTS From all 24 susceptible A.baumannii isolates 10 were selected,including 6 multi-colonial blaOXA23 harboring strains.Plasmid conjugation experiments and Southern blotting experiments demonstrated that blaOXA-23 was not associated with integrons.CONCLUSIONS BlaOXA-23 may exist in a certain subset of apparently carbapenem sensitive Acinetobacter strains.When under consecutive selective pressure,bacteria harboring blaOXA-23 become the predominant group and subsequently the antibiotics resistance properties appear.It highlights the reasonable use of this category of antibiotics.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2007年第12期1465-1468,共4页 Chinese Journal of Nosocomiology
基金 安徽省高校自然科学研究项目(2006kj49B)
关键词 鲍氏不动杆菌 Β-内酰胺类 碳青酶烯类 耐药 核酸杂交 Acinetobacter baumannii,Beta-lactam,Carbapenems,Resistance,Nucleic acid hybridization
  • 相关文献

参考文献13

  • 1Afzal-Shah M,Woodford N,Livermore DM.Characterization of OXA-25,OXA-26 and OXA-27,molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii[J].Antimicrob Agents Chemother,2001,45(2):583-588.
  • 2Poirel L,Marque S,Heritier C,et al.OXA-58,a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii[J].Antimicrob Agents Chemother,2005,49(1):202-208.
  • 3Fernandez-Cuenca F,Martinez-Martinez L,Conejo MC,et al.Relationship between beta-lactamase production,outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of Acinetobacter baumannii[J].J Antimicrob Chemother,2003,51 (3):565-574.
  • 4张永,唐英春,陆坚,张扣兴.鲍曼不动杆菌对亚胺培南耐药分子机制的研究[J].中国抗生素杂志,2005,30(4):217-221. 被引量:71
  • 5Nordmann P,Poirel L.Emerging carbapenemases in Gramnegative aerobes[J].Clin Microbiol Infect,2002,8 (6):321-331.
  • 6Brown S,Young HK,Amyes SG.Characterization of OXA-51,a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina[J].Clin Microbiol Infect,2005,11 (1):15-23.
  • 7Urban C,Segal-Maurer S,Rahal JJ.Considerations in control and treatment of nosocomial infections due to multidrugresistant Acinetobacter baumannii[J].Clin Infect Dis,2003,36(10):1268-1274.
  • 8张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 9糜祖煌,黄支密,秦玲.鲍氏不动杆菌耐药性和氨基糖苷类修饰酶、β-内酰胺酶基因研究[J].中华医院感染学杂志,2004,14(9):968-971. 被引量:136
  • 10胡志东,田彬,徐海茹,李琴,钟述猷.临床患者分离的鲍氏不动杆菌耐药性分析[J].中华医院感染学杂志,2005,15(1):112-114. 被引量:57

二级参考文献64

  • 1张翊,卢建平.鲍氏不动杆菌感染及耐药性变化的趋势[J].中华医院感染学杂志,2004,14(3):341-343. 被引量:91
  • 2于秀娟,姚苹,孔庆莲.呼吸系统不动杆菌感染的多重耐药性与耐药基因的检测[J].中华医院感染学杂志,2004,14(4):369-372. 被引量:16
  • 3糜祖煌,黄支密,秦玲.鲍氏不动杆菌耐药性和氨基糖苷类修饰酶、β-内酰胺酶基因研究[J].中华医院感染学杂志,2004,14(9):968-971. 被引量:136
  • 4Karlowsky JA, Deborahc,et al. Surveillance for antlmicrobial susceptibility among clinical isolates of Pseudomonas aerugi-nosa and Acinetobacter baumannii from hospitalized patients in the United States,1998 to 2001 [J]. Antimictob AgentsChemother, 2003, 47(5): 1681-1688.
  • 5Hsueh PR , Teng LJ , Chen CY , et al . Pandrug resistant Acinetobacter baumannii causing nosocomial infections in a uni-versity hospital, Taiwan[J]. Emerg Infect Dis, 2002, 8(8):827-832.
  • 6National Committee for Clinical Laboratory Standards. Perfor-mance standards for antimicrobial susceptibility testing [S].Approved Standard M100-S12. NCCLS, 2002.
  • 7Poirel L, Menuteau O, et al. Outbreak of extended spectrum β lactamase VEB-1 producing isolates of Acinetobacter bauman-nil in a French hospital[J]. J Clin Microbiol, 2003, 41 (8):3542-3547.
  • 8Ribera A, Ruiz J, Vila J. Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii[J]. Antimicrob Agents Chemothtr, 2003, 47(7): 2310-2312.
  • 9Jean SS, Teng LT, Hsueh PR, et al. Antimicrobial suscepti-bility among clinical isolates of extended spectrum cephalosporin resistant Gram negative bacteria in a Taiwan Residents university hospital [J]. J Antimicrob Chemother, 2002, 49(1): 69-76.
  • 10Hsueh PR. Liu YC, Yang D, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in in-tensive care units in 2000 in Taiwan[J]. Microb Drug Resist,2001,7(4) :373-382.

共引文献424

同被引文献29

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部